WayPoint Biomedical Holdings, Inc. (WYPH)

Market Cap	33.36K +500.0%
Revenue (ttm)	33.24K
Net Income	-806.27K
EPS	-0.02
Shares Out	55.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,250
Open	0.0006
Previous Close	n/a
Day's Range	0.0006 - 0.0006
52-Week Range	0.0002 - 0.0021
Beta	-87.71
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About WYPH

WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2004
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: WYPH

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error